Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience
- 18 May 2019
- journal article
- research article
- Published by Springer Nature in La radiologia medica
- Vol. 124 (9) , 870-876
Abstract
To report on the safety and clinical benefit of robotic stereotactic radiotherapy (SBRT) for liver oligometastatic colorectal cancer (CRC).Keywords
This publication has 26 references indexed in Scilit:
- Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacyOncology Letters, 2016
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancerAnnals of Oncology, 2016
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Is Stereotactic Body Radiation Therapy an Attractive Option for Unresectable Liver Metastases? A Preliminary Report From a Phase 2 TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- Stereotactic body radiation therapy: The report of AAPM Task Group 101Medical Physics, 2010
- Colorectal Liver MetastasesArchives of Surgery, 2008
- Stereotactic Body Radiation Therapy in Multiple Organ SitesJournal of Clinical Oncology, 2007
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004